<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03993145</url>
  </required_header>
  <id_info>
    <org_study_id>2018/1803</org_study_id>
    <nct_id>NCT03993145</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus ('Mom's Healthy Heart')</brief_title>
  <official_title>Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus: A Pilot Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvard Medical School (HMS and HSDM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helse Nord-Tr√∏ndelag HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this pilot intervention study is to develop and test a tailored web-based&#xD;
      lifestyle modification program for women with recent preeclampsia or gestational diabetes.&#xD;
      Women will start the study 3-15 months postpartum. After obtaining written informed consent&#xD;
      and confirmation of eligibility criteria, eligible women will be included in the pilot study&#xD;
      using a single arm study design (all women will be assigned to the lifestyle intervention&#xD;
      program). Participants will be provided access to a web-based lifestyle intervention program&#xD;
      with personalized coaching from a registered dietician.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 7, 2020</start_date>
  <completion_date type="Actual">May 4, 2021</completion_date>
  <primary_completion_date type="Actual">May 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment</measure>
    <time_frame>baseline</time_frame>
    <description>Proportion of eligible patients enrolled in the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of participants kept in the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of participants kept in the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of participants following study program (visiting the study's website and having scheduled phone conversations with the dietician)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of participants following study program (visiting the study's website and having scheduled phone conversations with the dietician)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to Norwegian food-based dietary guidelines</measure>
    <time_frame>3 months</time_frame>
    <description>We will use the NORDIET food frequency questionnaire to measure adherence to the qualitative recommendations of the Norwegian food-based dietary guidelines (FBDG) (Henriksen et al. 2018). We will measure the proportion of participants complying with the Norwegian FBDG.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to Norwegian food-based dietary guidelines</measure>
    <time_frame>6 months</time_frame>
    <description>We will use the NORDIET food frequency questionnaire to measure adherence to the qualitative recommendations of the Norwegian food-based dietary guidelines (Henriksen et al. 2018). We will measure the proportion of participants complying with the Norwegian FBDG.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in physical activity levels</measure>
    <time_frame>baseline, 3 months</time_frame>
    <description>Changes in physical activity levels assessed by physical activity sensors (two tri-axial accelerometers, AX3 Axivity, one on the thigh and second on lower back)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in physical activity levels</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>Changes in physical activity levels assessed by physical activity sensors (two tri-axial accelerometers, AX3 Axivity, one on the thigh and second on lower back)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body weight</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Changes in body weight measured in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body weight</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Changes in body weight measured in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Changes in blood pressure in mmHg (measured three times at 1-minute intervals after the participant has come to rest, using an automatic oscillometric method with cuff size adjusted to arm circumference)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Changes in blood pressure in mmHg (measured three times at 1-minute intervals after the participant has come to rest, using an automatic oscillometric method with cuff size adjusted to arm circumference)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in total cholesterol</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Changes in total cholesterol measured in mmol/l in non fasting blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in total cholesterol</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Changes in total cholesterol measured in mmol/l in non fasting blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in HbA1c</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Changes in HbA1c measured in mmol/l in non fasting blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in HbA1c</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Changes in HbA1c measured in mmol/l in non fasting blood samples</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Participant satisfaction</measure>
    <time_frame>9 months</time_frame>
    <description>Participants will complete qualitative surveys and participate in semi-structured interviews to measure their satisfaction with the intervention program.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Pre-Eclampsia</condition>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Web-based lifestyle intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will be provided access to web-based lifestyle intervention program with personalized coaching from a clinical dietician</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Web-based lifestyle intervention</intervention_name>
    <description>Lifestyle intervention program including educational modules on diet and physical activity with visual and audio. Phone conversation with the clinical dietician at week 1, week 3, week 6, week 12 and month 6 (completion of the study).</description>
    <arm_group_label>Web-based lifestyle intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of preeclampsia or gestational diabetes in recent pregnancy, confirmed by&#xD;
             medical record review&#xD;
&#xD;
          -  capable to speak and read Norwegian&#xD;
&#xD;
          -  access to internet enabled mobile devices that use either iOS or Android operating&#xD;
             systems&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of chronic hypertension or diabetes mellitus&#xD;
&#xD;
          -  current use of blood pressure lowering medication&#xD;
&#xD;
          -  medication known to affect glucose tolerance&#xD;
&#xD;
          -  active self-reported eating disorder&#xD;
&#xD;
          -  history of heart disease, stroke or kidney disease&#xD;
&#xD;
          -  history of gastric bypass or bowel surgery resulting in malabsorption&#xD;
&#xD;
          -  active medical problems that would interfere with following the diet, or with changes&#xD;
             in blood pressure and/or weight&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siri Forsmo, md prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology NTNU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Levanger sykehus</name>
      <address>
        <city>Levanger</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 18, 2019</study_first_submitted>
  <study_first_submitted_qc>June 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mentoring</keyword>
  <keyword>Healthy life style</keyword>
  <keyword>Postpartum Period</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

